Skip to main content
SpringerLink
Log in

MASCC/ESMO Antiemetic Guidelines: Introduction to the 2016 guideline update

  • Special Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Roila F, Herrstedt J, Aapro M, Gralla RJ, Einhorn LH, Ballatori E, Bria E, Clark-Snow RA, Espersen BT, Feyer P, Grunberg SM, Hesketh PJ, Jordan K, Kris MG, Maranzano E, Molassiotis A, Morrow G, Olver I, Rapoport BL, Rittenberg C, Saito M, Tonato M, Warr D, ESMO/MASCC Guidelines Working Group (2010) Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol 21(Suppl 5):v232–v243

    Article  PubMed  Google Scholar 

  2. Tonato M (1998) Introduction. Support Care Cancer 6:193

    Article  Google Scholar 

  3. Gralla RJ, Osoba D, Kris MG, Kirkbride P, Hesketh PJ, Chinnery LW, Clark-Snow R, Gill DP, Groshen S, Grunberg S, Koeller JM, Morrow GR, Perez EA, Silber JH, Pfister DG (1999) Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology. J Clin Oncol 17(9):2971–2994

    CAS  PubMed  Google Scholar 

  4. Aapro M, Molassiotis A, Dicato M, Peláez I, Rodríguez-Lescure Á, Pastorelli D, Ma L, Burke T, Gu A, Gascon P, Roila F; PEER investigators. 2012. The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER). Ann Oncol; 23(8):1986–1992.

Download references

Author information

Authors and Affiliations

  1. School of Nursing, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong

    A. Molassiotis

  2. Multidisciplinary Oncology Institute, Clinique de Genolier, Genolier, Switzerland

    M. Aapro

  3. Department of Oncology, Odense University Hospital, Odense, Denmark

    J. Herrstedt

  4. Albert Einstein College of Medicine, Jacobi Medical Center, New York, USA

    R. Gralla

  5. Medical Oncology, Santa Maria Hospital, Terni, Italy

    F. Roila

Authors
  1. A. Molassiotis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Aapro
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Herrstedt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Gralla
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. Roila
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Molassiotis.

Ethics declarations

Conflict of interest

AM reports grants or honoraria from MSD Merck; Helsinn; Tesaro; Norgine; Acacia Pharma. MA: Helsinn; Tesaro; MSD Merck; Roche. JH: Tesaro; Swedish Orphan Biovitrum. RG: Helsinn; MSD Merck; Tesaro; Eisai. FR: None declared.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Molassiotis, A., Aapro, M., Herrstedt, J. et al. MASCC/ESMO Antiemetic Guidelines: Introduction to the 2016 guideline update. Support Care Cancer 25, 267–269 (2017). https://doi.org/10.1007/s00520-016-3324-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-016-3324-x

Keywords

Search

Navigation